(Reuters) - Generic drugmaker Mylan NV reported a 31.2 percent rise in quarterly revenue, helped by demand for products it gained through the acquisition of Swedish drugmaker Meda last year.

Mylan's quarterly revenue jumps 31 percent
Read More
Bagikan Berita Ini
0 Response to "Mylan's quarterly revenue jumps 31 percent"
Posting Komentar